Rhumbline Advisers Amedisys Inc Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Amedisys Inc stock. As of the latest transaction made, Rhumbline Advisers holds 89,886 shares of AMED stock, worth $8.13 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
89,886
Previous 87,761 2.42%
Holding current value
$8.13 Million
Previous $8.06 Million 7.66%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$96.5 - $98.45 $205,062 - $209,206
2,125 Added 2.42%
89,886 $8.67 Million
Q2 2024

Aug 01, 2024
SELL
$90.4 - $96.77 $221,660 - $237,280
-2,452 Reduced 2.72%
87,761 $8.06 Million
Q1 2024

May 09, 2024
SELL
$92.15 - $95.24 $334,320 - $345,530
-3,628 Reduced 3.87%
90,213 $8.31 Million
Q4 2023

Feb 08, 2024
SELL
$91.15 - $95.89 $388,116 - $408,299
-4,258 Reduced 4.34%
93,841 $8.92 Million
Q3 2023

Nov 09, 2023
SELL
$89.84 - $94.08 $124,518 - $130,394
-1,386 Reduced 1.39%
98,099 $9.16 Million
Q2 2023

Aug 08, 2023
BUY
$73.99 - $92.6 $181,719 - $227,425
2,456 Added 2.53%
99,485 $9.1 Million
Q1 2023

May 11, 2023
SELL
$69.79 - $100.33 $69,720 - $100,229
-999 Reduced 1.02%
97,029 $7.14 Million
Q4 2022

Feb 14, 2023
BUY
$80.12 - $105.34 $273,048 - $358,998
3,408 Added 3.6%
98,028 $8.19 Million
Q3 2022

Nov 10, 2022
BUY
$96.79 - $131.14 $190,676 - $258,345
1,970 Added 2.13%
94,620 $9.16 Million
Q2 2022

Aug 11, 2022
BUY
$105.12 - $173.85 $490,384 - $811,010
4,665 Added 5.3%
92,650 $9.74 Million
Q1 2022

May 12, 2022
SELL
$124.79 - $178.09 $19,592 - $27,960
-157 Reduced 0.18%
87,985 $15.2 Million
Q4 2021

Feb 10, 2022
BUY
$136.32 - $184.41 $701,366 - $948,789
5,145 Added 6.2%
88,142 $14.3 Million
Q3 2021

Nov 12, 2021
SELL
$149.1 - $270.32 $80,514 - $145,972
-540 Reduced 0.65%
82,997 $12.4 Million
Q2 2021

Aug 05, 2021
SELL
$238.97 - $288.5 $504,943 - $609,600
-2,113 Reduced 2.47%
83,537 $20.5 Million
Q1 2021

May 06, 2021
SELL
$236.62 - $314.16 $389,949 - $517,735
-1,648 Reduced 1.89%
85,650 $22.7 Million
Q4 2020

Feb 10, 2021
SELL
$231.3 - $293.33 $330,527 - $419,168
-1,429 Reduced 1.61%
87,298 $25.6 Million
Q3 2020

Nov 12, 2020
SELL
$199.22 - $248.1 $606,425 - $755,216
-3,044 Reduced 3.32%
88,727 $21 Million
Q2 2020

Aug 13, 2020
SELL
$169.77 - $213.81 $1.01 Million - $1.28 Million
-5,969 Reduced 6.11%
91,771 $18.2 Million
Q1 2020

May 06, 2020
SELL
$137.21 - $202.02 $93,988 - $138,383
-685 Reduced 0.7%
97,740 $17.9 Million
Q4 2019

Feb 05, 2020
BUY
$122.85 - $167.13 $167,690 - $228,132
1,365 Added 1.41%
98,425 $16.4 Million
Q3 2019

Oct 23, 2019
BUY
$117.97 - $137.89 $493,586 - $576,931
4,184 Added 4.5%
97,060 $12.7 Million
Q2 2019

Aug 14, 2019
BUY
$108.08 - $129.67 $556,071 - $667,152
5,145 Added 5.86%
92,876 $11.3 Million
Q1 2019

May 01, 2019
BUY
$110.76 - $138.73 $960,621 - $1.2 Million
8,673 Added 10.97%
87,731 $10.8 Million
Q4 2018

Jan 31, 2019
BUY
$98.2 - $140.23 $1.32 Million - $1.88 Million
13,414 Added 20.43%
79,058 $9.26 Million
Q3 2018

Nov 07, 2018
SELL
$87.74 - $125.01 $268,747 - $382,905
-3,063 Reduced 4.46%
65,644 $8.2 Million
Q2 2018

Aug 06, 2018
BUY
$60.06 - $87.93 $124,744 - $182,630
2,077 Added 3.12%
68,707 $5.87 Million
Q1 2018

May 02, 2018
BUY
$50.51 - $62.74 $81,876 - $101,701
1,621 Added 2.49%
66,630 $4.02 Million
Q4 2017

Feb 09, 2018
BUY
$46.45 - $58.49 $420,744 - $529,802
9,058 Added 16.19%
65,009 $3.43 Million
Q3 2017

Nov 06, 2017
BUY
$47.05 - $55.96 $2.63 Million - $3.13 Million
55,951
55,951 $3.13 Million

Others Institutions Holding AMED

# of Institutions
297
Shares Held
28.5M
Call Options Held
181K
Put Options Held
1.04M
View Full List

About AMEDISYS INC

AMED Quotes by TradingView
  • Ticker AMED
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 32,492,000
  • Market Cap $2.94B
  • Description
  • Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal...
More about AMED
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email